Gail Boudreaux - 17 Jul 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: President and CEO, Director
Issuer ticker: ELV
Reported as of: 17 Jul 2026
Net transaction value: +$1,002,230
SEC form: 4
Accepted by SEC: 17 Jul 2026, 13:50:44 UTC
Prior SEC filing: 13 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Gail Boudreaux filed Form 4 for Elevance Health, Inc. (ELV) on 17 Jul 2026.

Key facts

This page summarizes Gail Boudreaux's Form 4 filing for Elevance Health, Inc. (ELV).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Jul 2026, 13:50.

Change

Previous filing in this sequence was filed on 13 Mar 2026.
Current net transaction value: +$1,002,230.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001287920 Primary reporting owner

BOUDREAUX GAIL

Relationship: President and CEO, Director
Address: 220 VIRGINIA AVENUE, INDIANAPOLIS
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Signature date: 17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Purchase

Transaction value: $249,159
Shares: +680
Change %: +0.4%
Price: $366.41
Shares after: 169,931
Date: 17 Jul 2026
Ownership: Direct
Footnotes: F1

ELV transaction

Common Stock

Purchase

Transaction value: $753,071
Shares: +2,045
Change %: +1.2%
Price: $368.25
Shares after: 171,976
Date: 17 Jul 2026
Ownership: Direct
Footnotes: F2

ELV holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 60
Date: 17 Jul 2026
Ownership: Shares Held in Spouse's Revocable Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F2

This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.